1128
M. S. Alam et al./Chemical Papers 69 (8) 1118–1129 (2015)
The bimodular G57-V577 polypeptide chain of the class B
Desai, N. C., Satodiya, H. M., Kotadiya, G. M., & Vaghani,
H. V. (2014). Synthesis and antibacterial and cytotoxic ac-
tivities of new N-3 substituted thiazolidine-2,4-dione deriva-
tives bearing the pyrazole moiety. Archives of Pharma-
ceutical Chemistry in Life Sciences, 347, 523–532. DOI:
10.1002/ardp.201300466.
Dinkova-Kostova, A. T., Abeygunawardana, C., & Talalay,
P. (1998). Chemoprotective properties of phenylpropenoids,
bis(benzylidene)cycloalkanones, and related Michael reaction
acceptors: Correlation of potencies as phase 2 enzyme induc-
ers and radical scavengers. Journal of Medicinal Chemistry,
41, 5287–5296. DOI: 10.1021/jm980424s.
Markham, K. R., & Geiger, H. (1994). 1H nuclear magnetic
resonance spectroscopy of flavonoids and their glycosides in
hexadeuterodimethylsulfoxide. In J. B. Harborne (Ed.), The
flavonoids: Advances in research since 1986 (Chapter 10, pp.
441–498). Boca Raton, FL, USA: Chapman & Hall/CRC.
Kiat, T. S., Pippen, R., Yusof, R., Ibrahim, H., Khalid, N., &
Rahman, N. A. (2006). Inhibitory activity of cyclohexenyl
chalcone derivatives and flavonoids of fingerroot, Boesen-
bergia rotunda (L.), towards dengue-2 virus NS3 protease.
Bioorganic & Medicinal Chemistry Letters, 16, 3337–3340.
DOI: 10.1016/j.bmcl.2005.12.075.
penicillin-binding protein 3 of Escherichia coli catalyzes pep-
tide bond formation from thiolesters and does not catalyze
glycan chain polymerization from the lipid II intermediate.
Journal of Bacteriology, 179, 6005–6009.
Agrawal, N. N., & Soni, P. A. (2007). Synthesis of pyrazole
and isooxazole in triethanolamine medium. Indian Journal
of Chemistry, Section B, 46B, 532–534.
Aichaoui, H., Guenadil, F., Kapanda, C. N., Lambert, D.
M., McCurdy, C. R., & Poupaert, J. H. (2009). Synthe-
sis and pharmacological evaluation of antioxidant chalcone
derivatives of 2(3H)-benzoxazolones. Medicinal Chemistry
Research, 18, 467–476. DOI: 10.1007/s00044-008-9143-y.
Alam, M. S., & Lee, D. U. (2011). Cytotoxic and antimicrobial
properties of furoflavones and furochalcones. Journal of the
Korean Society for Applied Biological Chemistry, 54, 725–
730. DOI: 10.3839/jksabc.2011.109.
Alam, M. S., Nam, Y. J., & Lee, D. U. (2013). Synthesis
and evaluation of (Z)-2,3-diphenylacrylonitrile analogs as
anti-cancer and anti-microbial agents. European Journal of
Medicinal Chemistry, 69, 790–797. DOI: 10.1016/j.ejmech.
2013.08.031.
Alcaráz, L. E., Blanco, S. E., Puig, O. N., Tomás, F., & Fer-
retti, F. H. (2000). Antibacterial activity of flavonoids against
methicillin-resistant Staphylococcus aureus strains. Journal
of Theoretical Biology, 205, 231–240. DOI: 10.1006/jtbi.
2000.2062.
Alves, M. J., Froufe, H. J. C., Costa, A. F. T., Santos, A. F.,
Oliveira, L. G., Osório, S. R. M., Abreu, R. M. V., Pintado,
M., & Ferreira, I. C. F. R. (2014). Docking studies in tar-
get proteins involved in antibacterial action mechanisms: Ex-
tending the knowledge on standard antibiotics to antimicro-
bial mushroom compounds. Molecules, 19, 1672–1684. DOI:
10.3390/molecules19021672.
Awasthi, S. K., Mishra, N., Kumar, B., Sharma, M., Bhat-
tacharya, A., Mishra, L. C., & Bhasin, V. K. (2009). Po-
tent antimalarial activity of newly synthesized substituted
chalcone analogs in vitro. Medicinal Chemistry Research, 18,
407–420. DOI: 10.1007/s00044-008-9137-9.
Battenberg, O. A., Yang, Y., Verhelst, S. H. L., & Sieber, S.
A. (2013). Target profiling of 4-hydroxyderricin in S. aureus
reveals seryl-tRNA synthetase binding and inhibition by co-
valent modification. Molecular BioSystems, 9, 343–351. DOI:
10.1039/c2mb25446h.
Konaklieva, M. I. (2014). Molecular targets of β-lactam-based
antimicrobials: Beyond the usual suspects. Antibiotics, 3,
128–142. DOI: 10.3390/antibiotics3020128.
Lahsasni, S. A., Al Korbi, F. H., & Abdel-Aziz Aljaber, N.
(2014). Synthesis, characterization and evaluation of antioxi-
dant activities of some novel chalcones analogues. Chemistry
Central Journal, 8, 32–40. DOI: 10.1186/1752-153x-8-32.
Liu, X. L., Xu, Y. J., & Go, M. L. (2008). Functionalized
chalcones with basic functionalities have antibacterial ac-
tivity against drug sensitive Staphylococcus aureus. Euro-
pean Journal of Medicinal Chemistry, 43, 1681–1687. DOI:
10.1016/j.ejmech.2007.10.007.
Mahmoodi, N., Besharati-Seidani, T., Motamed, N., & Mah-
moodi, N. O. (2014). Anti-cancerous effect of 4,4ꢀ-dihydr-
oxychalcone ((2E,2ꢀE)-3,3ꢀ-(1,4-phenylene)bis(1-(4-hydroxy-
phenyl)prop-2-en-1-one)) on T47D breast cancer cell line.
Annual Research & Review in Biology, 4, 2045–2052. DOI:
10.9734/arrb/2014/8484.
Modzelewska, A., Pettit, C., Achanta, G., Davidson, N. E.,
Huang, P., & Khan, S. R. (2006). Anticancer activities of
novel chalcone and bis-chalcone derivatives. Bioorganic &
Medicinal Chemistry, 14, 3491–3495. DOI: 10.1016/j.bmc.
2006.01.003.
Muroi, H., Nihei, K., Tsujimoto, K., & Kubo, I. (2004). Syner-
gistic effects of anacardic acids and methicillin against methi-
cillin resistant Staphylococcus aureus. Bioorganic & Medic-
inal Chemistry, 12, 583–587. DOI: 10.1016/j.bmc.2003.10.
046.
Berthelot, J., Benammar, Y., & Desmazi`eres, B. (1995). Action
of tetrabutylammonium tribromide with para-substituted
chalcones in protic and aprotic media. Canadian Journal of
Chemistry, 73, 1526–1530. DOI: 10.1139/v95-189.
Blois, M. S. (1958). Antioxidant determinations by the use
of
a stable free radical. Nature, 181, 1199–1200. DOI:
10.1038/1811199a0.
Murray, P. R., Rosenthal, K. S., & Pfaller, M. A. (2006). Mi-
crobiología médica (5th ed.). Madrid, Spain: Elsevier Espana.
(in Spanish)
Nielsen, S. F., Larsen, M., Boesen, T., Schønning, K., & Kro-
mann, H. (2005). Cationic chalcone antibiotics. Design, syn-
thesis, and mechanism of action. Journal of Medicinal Chem-
istry, 48, 2667–2677. DOI: 10.1021/jm049424k.
Charpentier, X., Chalut, C., Rémy, M. H., & Masson, J. M.
(2002). Penicillin-binding proteins 1a and 1b form indepen-
dent dimers in Escherichia coli. Journal of Bacteriology, 184,
3749–3752. DOI: 10.1128/jb.184.13.3749-3752.2002.
Cheenpracha, S., Karalai, C., Ponglimanont, C., Subhad-
hirasakul, S.,
& Tewtrakul, S. (2006). Anti-HIV-1 pro-
tease activity of compounds from Boesenbergia pandurata.
Bioorganic & Medicinal Chemistry, 14, 1710–1714. DOI:
10.1016/j.bmc.2005.10.019.
Contreras-Martel, C., Amoroso, A., Woon, E. C., Zervosen, A.,
Inglis, S., Martins, A., Verlaine, O., Rydzik, A. M., Job,
V., Luxen, A., Joris, B., Schofield, C. J., & Dessen, A.
(2011). Structure-guided design of cell wall biosynthesis in-
hibitors that overcome β-lactam resistance in Staphylococcus
aureus (MRSA). ACS Chemical Biology, 6, 943–951. DOI:
10.1021/cb2001846.
Nishino, C., Enoki, N., Tawata, S., Mori, A., Kobayashi,
K.,
& Fukushima, M. (1987). Antibacterial activity of
flavonoids against Staphylococcus epidermidis, a skin bac-
terium. Agricultural and Biological Chemistry, 51, 139–143.
DOI: 10.1271/bbb1961.51.139.
Nowakowska, Z. (2007). A review of anti-infective and anti-
inflammatory chalcones. European Journal of Medicinal
Chemistry, 42, 125–137. DOI: 10.1016/j.ejmech.2006.09.019.
Piantadosi, C., Hall, I. H., Irvine, J. L., & Carlson, G. L. (1973).
Cycloalkanones. 2. Synthesis and biological activity α,αꢀ-
Brought to you by | New York University Bobst Library Technical Services
Authenticated
Download Date | 6/9/15 1:05 PM